Previous close | 109.25 |
Open | 109.79 |
Bid | 108.43 x 900 |
Ask | 0.00 x 1300 |
Day's range | 108.59 - 109.98 |
52-week range | 101.24 - 142.60 |
Volume | |
Avg. volume | 5,134,569 |
Market cap | 190.883B |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | 22.76 |
EPS (TTM) | 4.79 |
Earnings date | 18 Oct 2022 - 24 Oct 2022 |
Forward dividend & yield | 1.88 (1.72%) |
Ex-dividend date | 14 July 2022 |
1y target est | 127.91 |
This week, in legal news Yahoo Finance is following stalled legislation that would have reined in Big Tech; lawsuits piling up against formula maker Abbott; and a simmering legal feud between Twitter and Tesla CEO Elon Musk.
Abbott Laboratories' growth looks much less impressive after removing sales from COVID-19 diagnostics.
Abbott (NYSE: ABT) and WW International, Inc. ("WeightWatchers" or "WW") today announced a strategic partnership that will help people living with diabetes better understand and manage their diabetes and weight. The companies are working together to integrate WeightWatchers' diabetes-tailored weight management program with Abbott's portfolio of FreeStyle Libre® products to create a seamless mobile experience that will give people living with diabetes the information and insights needed to make h